Access to Quality Medicines & Other Technologies
The Access to Quality Medicines and other Technologies Task Force (AQMTF) advises APLMA on options for improving the availability of, and access to, quality medicines, diagnostics and other products to support malaria elimination in Asia Pacific by 2030.
The AQMTF will examine arrangements in the region for the regulation, production, procurement and distribution of medicines, diagnostics, mosquito nets, insecticides and other products used in the control and management of malaria (‘malaria control products’) and develop options for:
The AQMTF will collaborate with, and build on the work of, existing global and regional organisations and networks involved in malaria control and management, to avoid duplication and accelerate progress.
The AQMTF is co-chaired by the Secretary of the Department of Health, Australia and the Secretary of the Ministry of Health and Family Welfare, India.
The AQMTF comprises senior policy officials and experts from regional countries with influence and interest in improving access to high quality medicines, diagnostics and other products, together with representatives of international organisations and non-governmental organisations with interest and expertise in malaria control, including the World Health Organization (WHO). Membership will be by invitation issued by the co-chairs in consultation with the WHO.
The AQMTF will consult with civil society and with malaria control product manufacturers, including in the private sector, as appropriate.
Meetings have been convened by the co-chairs, with Secretariat support provided by the Asian Development Bank. The AQMTF will present its findings to APLMA leaders in August 2014.
|2nd AQMTF Meeting||9-10 June, 2014||Manila, Philippines|
|1st AQMTF Meeting||12-13 March, 2014||Sydney, Australia|
|Outcomes Statement: 1st AQMTF meeting|
|Outcomes Statement: 2nd AQMTF meeting|
|Regulation of ACTs in Asia Pacific|
|Ensuring Access to Malaria Commodities for High-Risk Populations|
|Market interventions to improve access to quality medicines and diagnostics|
|Market landscape antimalaria commodities|
|Frameworks and Processes for Malaria Control, Drug Quality and Artemisinin Resistance in Asia|
|Desk-based Market Analysis of Supply Side Issues for Antimalarial Commodities|
|An Overview of Antimalarial Commodity Issues in the Asia Pacific Region|
|Overview of WHO Pesticides Evaluation Scheme (WHOPES)|
|Products under WHOPES Evaluation|
|Malaria Medicines Regulators’ Group Report|
|Synthesis of the Current Evidence on the Multiple Causes of Malaria Drug Resistance|
|Case Study 1: Community Health Workers|
|Case Study 2: Cambodia Justice Police|
|Case Study 3: Preventing Malaria in the region|
|Case Study 4: ACT Forecasting|
In recognition of the vital role regulatory authorities play in ensuring the availability of safe, effective and quality medicines and in-vitro diagnostics needed to reach the goal of malaria elimination by 2030, APLMA is facilitating the establishment of the Regional Regulatory Partnership for Malaria Elimination (RRPME).
The RRPME is a multi-stakeholder group comprising national regulatory authorities, technical agencies, academia, donors, product development partnerships, as well as policy and advocacy specialists.
The first meeting was held March 31- April 1, 2016 in Bangkok to explore the establishment of a Regional Regulatory Partnership for Malaria Elimination (RRPME), during which 12 recommendations were agreed upon. These recommendations were intended to support one of the six priority action items endorsed by Leaders as part of the APLMA Leaders Malaria Elimination Roadmap in 2015, namely to ensure high quality malaria services, tests, medicines, nets and insecticides.
It was also recognized from the inception that factors beyond the regulation of medical products must also be addressed as part of a comprehensive malaria elimination strategy, including procurement and pricing policies and supply chain issues, as well as the regulation and use of vector control products such as bed nets and insecticides.
The purpose of the second meeting on the RRPME, hosted by the Government of Indonesia, is to formalize the partnership and initiate a plan of regulatory support to priority countries, guided by an overarching strategic plan and operating model, informed by the latest intelligence on products of interest and the regulatory needs of the target countries.
The specific objectives of the Jakarta meetings are to:
Building upon the above, the following considerations/principles should be taken into account in developing a strategic plan: